Keywords: vectura, pd, drug, successful, ph, ii, study

Vectura's PD drug successful in Ph II study

Article | 14 August 2006

Print This

UK-based Vectura, a specialist in the development of inhaled drug formulations, says that it has successfully completed a Phase II ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in